業績 2022年

Fujiwara Y, Urata T, Niiya D, Yano T, Nawa Y, Yoshida I, Imai T, Sunami K, Fujii S, Ennishi D, Maeda Y, Hiramatsu Y. Higher incidence of thrombocytopenia during obinutuzumab plus bendamustine therapy for untreated follicular lymphoma: a retrospective analysis by the Okayama Hematology Study Group. Int J Hematol. 2022; 115: 811-815
Fujishita K, Sando Y, Oka S, Fujisawa Y, Machida T, Imai T. Extending Treatment Intervals of R-CHOP Therapy Might Be Acceptable for Some Patients with Non-indolent Non-Hodgkin’s B-cell Lymphoma. Acta Med Okayama. 2022; 76: 17-24
Kitamura W, Fujii N, Nawa Y, Fujishita K, Sugiura H, Yoshioka T, Fujiwara Y, Usui Y, Fujii K, Fujiwara H, Asada N, Nishimori H, Matsuoka KI, Maeda Y. Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological Study Group. Int J Hematol. 2022; 115: 515-524

Matsumoto K, Fujishita K, Matsuda M, Oka S, Fujisawa Y, Imai T, Machida T. Idiopathic Pneumonia Syndrome Refractory to Ruxolitinib after Post-Transplant Cyclophosphamide-based Haploidentical Hematopoietic Stem Cell Transplantation: Lung Pathological Findings from an Autopsy Case. Acta Med Okayama. 2022; 76: 609-615
Hayashino K, Matsuda M, Fujishita K, Iwata J, Mizobuchi M, Uemura M, Yorita K, Maeshima A, Imai T. Acute undifferentiated leukemia limited to neck lymph nodes and a large mediastinal mass. J Clin Exp Hematop. 2022; 115: 811-815
Hayashino K, Matsuda M, Negoro T, Fujishita K, Imai T. A rare case of multiple myeloma with Auer rod-like inclusions in plasma cells. Int J Hematol. 2022; 116: 461-462

Yusuke Inoue, Keigo Fujishita, Hiroki Iriyoshi, Masayuki Matuda, Satoshi Oka, Takuya Machida, Toshi Imai. A methotrexate related small lymphocytic lymphoma presenting Richter syndrome. 第84回日本血液学会学術集会. 福岡, 2022
Keigo Fujishita, Masayuki Matsuda, Satoshi Oka, Hiroki Iriyoshi, Takuya Machida, Toshi Imai, Yusuke Inoue, Takeshi Taketani. A myeloid neoplasm with germline RUNX1 mutation harbouring germline compound heterozygous mutation. 第84回日本血液学会学術集会. 福岡, 2022